Biomimetics
Heartland Bridge Capital Announces Potential Investment
Published in Biotech Business Week, August 8th, 2011
2011 AUG 8 -- Heartland Bridge Capital (OTCBB:HLBC) announced that it has signed a term sheet to make an investment in HepatoChem Inc. HepatoChem, headquartered in Cambridge, MA, offers pharmaceutical and biotech companies reliable and efficient access to small molecule metabolites. HepatoChem's innovative technology uses biomimetic catalysts to mimic the metabolic function of the liver. This unique technology, developed in collaboration with Professor John Groves at Princeton University, enables the production of metabolites faster and with greater cost-effectiveness than any other available technology.
"We are very excited at the opportunity to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Information Technology
Acentia Launches with New Brand Identity and Website to Represent Its Mission Supporting Customers on Programs of National Significance - Crohn's Disease
American Idol Contestant Casey Abrams Launches Nationwide Contest to Raise Awareness About Inflammatory Bowel Disease - Biotechnology
Maria K Woods, Esq Named Director, Compliance and Privacy at Publicis Touchpoint Solutions, Inc - Biotechnology
Provincial Investment Supports Commercialization of Leading-Edge Molecular Diagnostic Screening Technology - Biotechnology
TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation - IntertechPira
Dates Announced for IntertechPira's 10th Annual Phosphor Global Summit - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
